- Home
- CPAY vs WST Comparison
CPAY vs WST Comparison
Compare CPAY & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- WST
- Stock Information
- Founded
- CPAY 1986
- WST 1923
- Country
- CPAY United States
- WST United States
- Employees
- CPAY N/A
- WST N/A
- Industry
- CPAY EDP Services
- WST Medical/Dental Instruments
- Sector
- CPAY Technology
- WST Health Care
- Exchange
- CPAY Nasdaq
- WST Nasdaq
- Market Cap
- CPAY 24.1B
- WST 23.2B
- IPO Year
- CPAY 2010
- WST N/A
- Fundamental
- Price
- CPAY $370.75
- WST $321.13
- Analyst Decision
- CPAY Buy
- WST Buy
- Analyst Count
- CPAY 12
- WST 3
- Target Price
- CPAY $376.73
- WST $460.33
- AVG Volume (30 Days)
- CPAY 533.4K
- WST 551.1K
- Earning Date
- CPAY 11-07-2024
- WST 10-24-2024
- Dividend Yield
- CPAY N/A
- WST 0.26%
- EPS Growth
- CPAY 9.84
- WST N/A
- EPS
- CPAY 14.01
- WST 6.74
- Revenue
- CPAY $3,877,478,000.00
- WST $2,876,400,000.00
- Revenue This Year
- CPAY $8.44
- WST N/A
- Revenue Next Year
- CPAY $11.88
- WST $6.22
- P/E Ratio
- CPAY $26.46
- WST $47.64
- Revenue Growth
- CPAY 4.68
- WST N/A
- 52 Week Low
- CPAY $247.10
- WST $265.00
- 52 Week High
- CPAY $385.30
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- CPAY 56.56
- WST 52.66
- Support Level
- CPAY $376.60
- WST $316.20
- Resistance Level
- CPAY $384.80
- WST $326.58
- Average True Range (ATR)
- CPAY 6.78
- WST 8.86
- MACD
- CPAY -1.16
- WST -0.51
- Stochastic Oscillator
- CPAY 47.24
- WST 50.66
About CPAY Corpay Inc.
Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.